These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37967856)

  • 1. Effects of Exogenous Erythropoietin on Rabbit (
    Levine JK; Seixas JN; Ritter JM; Liew AY; Tansey CM
    Comp Med; 2023 Dec; 73(6):439-445. PubMed ID: 37967856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human erythropoietin and health-related quality of life of AIDS patients with anemia.
    Revicki DA; Brown RE; Henry DH; McNeill MV; Rios A; Watson T
    J Acquir Immune Defic Syndr (1988); 1994 May; 7(5):474-84. PubMed ID: 8158542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the efficacy of a biogeneric recombinant human erythropoietin alfa in the correction of post-transplantation anemia: a randomized comparative trial with Eprex.
    Beiraghdar F; Panahi Y; Einollahi B; Torkaman M; Mohammadi R; Marzony ET; Sahebkar A
    Clin Lab; 2012; 58(11-12):1179-85. PubMed ID: 23289187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Overview of four clinical trials.
    Henry DH; Beall GN; Benson CA; Carey J; Cone LA; Eron LJ; Fiala M; Fischl MA; Gabin SJ; Gottlieb MS
    Ann Intern Med; 1992 Nov; 117(9):739-48. PubMed ID: 1416576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
    Phair JP; Abels RI; McNeill MV; Sullivan DJ
    Arch Intern Med; 1993 Dec; 153(23):2669-75. PubMed ID: 8250662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does subcutaneous administration of recombinant human erythropoietin increase thrombotic events in total hip arthroplasty? A prospective thrombelastography analysis.
    Ruan RX; Bai CW; Zhang L; Huang CR; Pan S; Zhang XC; Zhu ZY; Zheng X; Guo KJ
    J Orthop Surg Res; 2020 Nov; 15(1):546. PubMed ID: 33213494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcutaneous recombinant human erythropoietin in children with renal anemia on continuous ambulatory peritoneal dialysis.
    Aufricht C; Balzar E; Steger H; Lothaller MA; Frenzel K; Kohlhauser C; Kiss H; Khoss AE; Kernova T
    Acta Paediatr; 1993 Nov; 82(11):959-62. PubMed ID: 8111178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of recombinant human erythropoietin (rh-EPO) in the treatment of anemia in hemodialysis patients: a multicenter Italian experience.
    Buccianti G; Colombi L; Battistel V
    Haematologica; 1993; 78(2):111-7. PubMed ID: 8349186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcutaneous recombinant human erythropoietin in chronic renal allograft dysfunction.
    Aufricht C; Marik JL; Ettenger RB
    Pediatr Nephrol; 1998 Jan; 12(1):10-3. PubMed ID: 9502558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the efficacy of a biogeneric recombinant human erythropoietin alfa in the management of renal anemia in patients on hemodialysis: a multi-center clinical trial.
    Beiraghdar F; Panahi Y; Einollahi B; Nemati E; Ghadiani MH; Sahebkar A; Maghsoudi N; Marzony ET
    Clin Lab; 2012; 58(7-8):737-45. PubMed ID: 22997974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of the anemia of hemodialysis patients with recombinant human erythropoietin.
    Schaefer RM; Kuerner B; Zech M; Denninger G; Borneff C; Heidland A
    Int J Artif Organs; 1988 Jul; 11(4):249-54. PubMed ID: 3410565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis.
    Pincus T; Olsen NJ; Russell IJ; Wolfe F; Harris ER; Schnitzer TJ; Boccagno JA; Krantz SB
    Am J Med; 1990 Aug; 89(2):161-8. PubMed ID: 2200263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietin for anemia.
    Med Lett Drugs Ther; 1989 Sep; 31(801):85-6. PubMed ID: 2671624
    [No Abstract]   [Full Text] [Related]  

  • 14. Renal function of pre-dialysis patients during treatment with recombinant human erythropoietin.
    Koene RA; Frenken LA
    Contrib Nephrol; 1991; 88():192-9; discussion 200. PubMed ID: 2040182
    [No Abstract]   [Full Text] [Related]  

  • 15. Randomized prospective comparison between erythropoietin and androgens in CAPD patients.
    Navarro JF; Mora C; Macía M; García J
    Kidney Int; 2002 Apr; 61(4):1537-44. PubMed ID: 11918762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of the anemia of chronic renal failure with subcutaneous recombinant human erythropoietin.
    Watson AJ; Gimenez LF; Cotton S; Walser M; Spivak JL
    Am J Med; 1990 Oct; 89(4):432-5. PubMed ID: 2220877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anemia induced by repeated exposure to cyanobacterial extracts with explorations of underlying mechanisms.
    Zhang X; Xie P; Li D; Shi Z; Wang J; Yuan G; Zhao Y; Tang R
    Environ Toxicol; 2011 Oct; 26(5):472-9. PubMed ID: 21910206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of recombinant human erythropoietin (EPO) to correct the anemia of end-stage renal disease: a progress report.
    Adamson W; Egrie JC; Browne JK; Downing MR; Eschbach W
    Behring Inst Mitt; 1988 Aug; (83):188-92. PubMed ID: 3071336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin.
    Beresford CH
    N Z Med J; 1989 Apr; 102(866):185-6. PubMed ID: 2652007
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of blood pressure changes during recombinant human erythropoietin therapy.
    Levin N
    Semin Nephrol; 1989 Mar; 9(1 Suppl 2):16-20. PubMed ID: 2669081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.